RESUMEN
BACKGROUND: Erythematotelangiectatic rosacea can be successfully treated using various laser and light-based devices. However, the use of narrow-band intense pulsed light for the treatment of erythematotelangiectatic rosacea has not been investigated in detail. This retrospective study aimed to analyze the clinical efficacy of narrow-band intense pulsed light (500-600 nm) for the treatment of erythematotelangiectatic rosacea among Chinese individuals. Methods: Patients with erythematotelangiectatic rosacea who had completed 3 sessions of treatment with narrow-band intense pulsed light and follow-up from July 2016 to December 2018 were retrospectively evaluated. Clinical improvement was assessed by 2 blinded dermatologists based on photographs obtained at each follow-up visit using the clinician erythema assessment scale and 5-grade scale. RESULTS: Forty-five patients with erythematotelangiectatic rosacea treated with narrow-band intense pulsed light were included in this study. The effectiveness and excellent rates after 3 treatment sessions were 68.9% and 35.6%, respectively. An average of 2 treatment sessions was required among patients who achieved good or excellent clearance of erythema and telangiectasia. Except for transient erythema and edema, no severe adverse effects were observed. CONCLUSIONS: Narrow-band intense pulsed light is a safe and effective treatment for erythematotelangiectatic rosacea. Even with a small number of treatment sessions, narrow-band intense pulsed light can deliver a significant therapeutic effect, which may be applicable in clinical practice. J Drugs Dermatol. 2023;22(11):1095-1098 doi:10.36849/JDD.4920.
Asunto(s)
Tratamiento de Luz Pulsada Intensa , Rosácea , Humanos , Pueblo Asiatico , Eritema/diagnóstico , Eritema/terapia , Estudios Retrospectivos , Rosácea/diagnóstico , Rosácea/terapiaRESUMEN
Melasma is an acquired hyperpigmentation disease characterized by hyperpigmented patches in sun-exposed areas that significantly impairs life quality. Topical treatments such as hydroquinone, retinoic acid, azelaic acid, chemical peels and laser treatments are among the main treatment options. In our study, we aimed to compare the effectiveness of Jessner peeling and 1064 nm Q-switched Nd:YAG laser in melasma treatment. For this purpose, Jessner peeling was applied to 20 patients and 1064 nm Q-switched Nd: YAG laser was applied to 19 patients of 39 melasma patients who applied to the cosmetology unit of Ege University department of dermatology and venereal diseases between November 2018-March 2020. Thirty seven patients completed the study. Changes in MASI, pigment and erythema scores measured by mexameter before and after treatment were compared for two groups. A statistically significant decrease in MASI scores, pigment and erythema scores was observed in both groups with no significant difference between two groups. In conclusion, in our study, it has been shown that Jessner peeling and 1064 nm Q-switched Nd:YAG laser are equally effective in treatment of melasma.
Asunto(s)
Quimioexfoliación , Hiperpigmentación , Láseres de Estado Sólido , Terapia por Luz de Baja Intensidad , Melanosis , Humanos , Láseres de Estado Sólido/uso terapéutico , Melanosis/radioterapia , Eritema/diagnóstico , Eritema/etiología , Resultado del TratamientoRESUMEN
BACKGROUND: Rosacea is a chronic inflammatory skin condition of varying severity that can significantly impact patient quality of life. Intense pulsed light (IPL) is an established treatment for rosacea-associated telangiectasia, inflammation, and erythema. This study assessed whether application of a phyto-corrective mask, gel, and resveratrol antioxidant serum after IPL treatment can improve outcomes and reduce procedure-related adverse effects. METHODS: In a prospective, open-label, split-face, 3-month study, 10 subjects with moderate-to-severe facial rosacea underwent IPL treatment on both sides of the face. The following were applied to the right side of the face only: phyto-corrective mask once weekly starting immediately after IPL; phyto-corrective gel twice daily; and resveratrol antioxidant treatment at night. Both sides of the face were treated with sunscreen. Subjects were assessed on Day 1, 1 and 3 months after IPL by three, independent evaluators using the 5-point Global Aesthetic Improvement Scale (GAIS). All subjects rated skin redness, hydration, and overall improvement on Day 1 and completed a patient satisfaction questionnaire at the 1- and 3-month visits. RESULTS: Ten women were enrolled, aged 44-72 years old, with moderate (n = 6) to severe (n = 4) rosacea. IPL was effective at reducing symptoms with rosacea classified as absent in five women and mild in five at the final 3-month visit. GAIS scores also revealed improvements on both sides of the face, but the skincare treated side showed continuous improvement over 3 months with all patients remaining at least "Improved", whereas there appeared to be a waning effect after 1 month with IPL alone. On Day 1 after IPL, all women reported less redness, improved hydration, and improved skin appearance on the right side of the face. Patient satisfaction was consistently rated higher on the right side of the face. CONCLUSION: Application of a phyto-corrective mask, gel, and resveratrol antioxidant serum may complement IPL treatment for rosacea by enhancing treatment outcomes and reducing procedure-related symptoms.
Asunto(s)
Rosácea , Protectores Solares , Adulto , Anciano , Antioxidantes/efectos adversos , Eritema/diagnóstico , Eritema/etiología , Eritema/terapia , Femenino , Humanos , Persona de Mediana Edad , Estudios Prospectivos , Calidad de Vida , Resveratrol , Rosácea/terapia , Resultado del TratamientoRESUMEN
OBJECTIVE: To identify the optimal intensity and duration of cupping that would minimize mechanical skin deformation. METHODS: We developed an optical measurement probe and system for measuring skin color values in real time. We applied cupping at the following five Bladder Meridian acupoints. To investigate optimal intensity, negative pressure intensity was increased every 2 min up to 80 kPa. To investigate optimal time, 10 measurement sites were selected and negative pressure intensities of 30, 60, and 80 kPa were applied for 5 min each. Skin color information was analyzed by the following skin color values: red color saturation, erythema index, and melanin index. RESULTS: The red color saturation and erythema index increased steadily up to 60 kpa negative pressure intensity, then decreased between 60 and 80 kPa. Therefore, maximal values were observed at 60 kPa. The melanin index consistently increased with increasing negative pressure intensity. The red color saturation and erythema index did not change after 20 s at 60 kPa negative pressure intensity. For negative pressure intensities below 80 kPa, significant changes in melanin index were not observed after 20 s. At 80 kPa negative pressure intensity, the melanin index exhibited an increasing pattern for 200 s, then showed no changes. CONCLUSIONS: To minimize skin deformation, 60 kPa and 20 s were the appropriate intensity and duration when using red color saturation and erythema index as diagnostic indexes. Because of the increasing pattern up to 80 kPa negative pressure intensity, the optimal intensity of melanin index could not be determined. When applying 80 kPa negative pressure intensity and using melanin index as the diagnostic index, we recommend a duration of 200 s.
Asunto(s)
Pigmentación de la Piel , Piel , Eritema/diagnóstico , Humanos , MelaninasRESUMEN
BACKGROUND: Skin rejuvenation can be achieved with minimally invasive treatments using energy-based devices that feature reduced side effects and downtime. Post-treatment care is key to minimize any potential side effects and skin reactions such as erythema, dryness, or dyschromia. OBJECTIVE: The objective of this study was to evaluate the efficacy and patient satisfaction of a novel carboxytherapy gel mask compared with petroleum-based lanolin-containing ointment to accelerate wound healing facial post-nanofractional radiofrequency treatment. METHODS AND MATERIALS: Ten subjects were enrolled in this pilot, prospective, randomized, single-blind study and randomized into two arms. One arm received one nanofractional radiofrequency treatment with ointment right after and four consecutive days of ointment applications twice a day, while the second arm followed this regimen with a carboxytherapy gel mask application right after and four consecutive days after treatment. Investigator, safety, and patient assessments were conducted at 24 hours and one-week post treatment. Safety was monitored throughout. The primary endpoint was defined as the degree of investigator global assessment (IGA) in photodamage, pigmentation, and wrinkles using standardized photographs. Secondary endpoints included investigator-rated degree of erythema, edema, crusting, exudation, percentage healing, improvement of skin quality, and patient satisfaction. RESULTS: Nine patients completed the study. There was improvement of one degree in IGA for photodamage, pigmentation and wrinkles in all patients using the carboxytherapy gel mask at the one-week follow up. Blinded investigator ratings showed significant improvement of dryness, erythema, edema, crusting, and percentage healing at the 24-hour follow up, with all patients remaining the same a week post treatment. All patients in the carboxytherapy group were satisfied with the treatment and had no adverse effects. Three patients in the petroleum-based lanolin-containing group experienced mild edema and acne breakout that resolved two weeks after treatment. CONCLUSION: Carboxytherapy delivered via a gel mask after skin rejuvenation procedures is a safe and effective strategy to improve clinical outcomes and reduce post-treatment side effects. J Drugs Dermatol. 20(4):461-465. doi:10.36849/JDD.5856.
Asunto(s)
Dióxido de Carbono/administración & dosificación , Técnicas Cosméticas/efectos adversos , Eritema/tratamiento farmacológico , Terapia por Radiofrecuencia/efectos adversos , Rejuvenecimiento , Administración Cutánea , Adulto , Eritema/diagnóstico , Eritema/etiología , Cara , Femenino , Geles , Humanos , Lanolina/administración & dosificación , Persona de Mediana Edad , Pomadas/administración & dosificación , Pomadas/química , Satisfacción del Paciente , Petróleo , Fotograbar , Proyectos Piloto , Estudios Prospectivos , Hipofraccionamiento de la Dosis de Radiación , Terapia por Radiofrecuencia/métodos , Índice de Severidad de la Enfermedad , Método Simple Ciego , Piel/diagnóstico por imagen , Piel/efectos de los fármacos , Piel/efectos de la radiación , Envejecimiento de la Piel/efectos de la radiación , Resultado del TratamientoRESUMEN
BACKGROUND: Intense Pulsed Light (IPL) is a non-coherent polychromatic broadband filtered flashlamp that emits light in the spectrum of approximately 400–1200 nm. Its effects on photorejuvenation are well documented. The goal of this study is to help practitioners better conceptualize and fine tune IPL device settings in order to produce the most effective and safest clinical outcome. MATERIALS/METHODS: This was a prospective study testing several filters (515 nm; 560 nm; 590 nm and 530–650; 900–1200 nm vascular filter), fluences, pulse durations, and pulse numbers (ie, multiple sequence pulsing or MSP) with a new IPL system. RESULTS: Post-procedure erythema response was more pronounced with increasing fluence, decreasing wavelength, fewer pulses and shorter pulse duration. The exception was the 515 nm filter with regard to pulse duration, which was observed to have a more pronounced response with longer pulse durations. The overall clinical outcome at the 4-week follow-up visit demonstrated greatest improvement in erythema and pigmentation using the 515 nm filter on a Fitzpatrick Skin Type III individual. CONCLUSION: Greatest clinical endpoint response at 4-week follow-up was observed with more robust initial responses. This was most apparent at higher fluence levels and fewer pulse counts. However, when the IPL is pushed to aggressive parameters, there is risk of hypopigmentation and hair loss as seen in this case study. Skin type is an important consideration when using IPL and MSP adds to its safety profile. J Drugs Dermatol. 2021;20(2):203-207. doi:10.36849/JDD.5638.
Asunto(s)
Alopecia/prevención & control , Técnicas Cosméticas/efectos adversos , Eritema/prevención & control , Hipopigmentación/prevención & control , Tratamiento de Luz Pulsada Intensa/efectos adversos , Anciano , Alopecia/diagnóstico , Alopecia/etiología , Dorso , Técnicas Cosméticas/instrumentación , Eritema/diagnóstico , Eritema/etiología , Estudios de Seguimiento , Humanos , Hipopigmentación/diagnóstico , Hipopigmentación/etiología , Tratamiento de Luz Pulsada Intensa/instrumentación , Tratamiento de Luz Pulsada Intensa/métodos , Masculino , Fotograbar , Estudios Prospectivos , Rejuvenecimiento , Estudios de Casos Únicos como Asunto , Piel/diagnóstico por imagen , Piel/efectos de la radiación , Pigmentación de la Piel/efectos de la radiación , Resultado del TratamientoRESUMEN
Objective: The expression of therapeutic proteins in plant oil body bioreactors has attracted much attention. But its safety is not yet clear. This article determines the risk of safety after using the drug. Methods: The oil body-linked oleosin-hEGF microgel emulsion (OBEME) was prepared by mixing the xanthan gum with suitable concentrations in an appropriate proportion. Skin irritation and sensitization reaction were investigated in rats and guinea pigs using OBEME as test article.Results: The OBEME did not produce dermal erythema/eschar or oedema responses. The dermal subacute and subchronic toxicity of OBEME were evaluated in accordance with OECD guidelines. Compared with the control group, the basic physical signs, such as weight, feed, drinking, excretion, and behaviour of experimental animals, were not abnormal. In addition, no abnormality was found in haematological parameters, biochemical indexes, relative organ weight, and histopathological observation of organs, and there was no significant difference compared with normal saline treatment group. Therefore, we conclude that OBEME has no toxic effects and is safe and reliable to be used for topical application.
Asunto(s)
Portadores de Fármacos/toxicidad , Factor de Crecimiento Epidérmico/toxicidad , Proteínas de Plantas/toxicidad , Proteínas Recombinantes de Fusión/toxicidad , Piel/efectos de los fármacos , Administración Cutánea , Animales , Reactores Biológicos/efectos adversos , Carthamus tinctorius/genética , Dermatitis por Contacto/diagnóstico , Dermatitis por Contacto/etiología , Dermatitis por Contacto/patología , Portadores de Fármacos/química , Evaluación Preclínica de Medicamentos , Emulsiones , Factor de Crecimiento Epidérmico/administración & dosificación , Factor de Crecimiento Epidérmico/genética , Eritema/inducido químicamente , Eritema/diagnóstico , Cobayas , Humanos , Gotas Lipídicas/química , Masculino , Microgeles , Proteínas de Plantas/administración & dosificación , Proteínas de Plantas/genética , Plantas Modificadas Genéticamente , Ratas , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/genética , Piel/inmunología , Piel/lesiones , Piel/patología , Pruebas de Toxicidad Aguda/métodos , Pruebas de Toxicidad Subaguda/métodos , Pruebas de Toxicidad Subcrónica/métodos , Cicatrización de Heridas/efectos de los fármacosAsunto(s)
Acrodermatitis/patología , Eritema/patología , Psoriasis/dietoterapia , Psoriasis/etiología , Zinc/deficiencia , Acrodermatitis/diagnóstico , Acrodermatitis/tratamiento farmacológico , Acrodermatitis/etiología , Adolescente , Biopsia , Suplementos Dietéticos , Eritema/diagnóstico , Eritema/etiología , Femenino , Pie/patología , Humanos , Psoriasis/diagnóstico , Psoriasis/patología , Resultado del Tratamiento , Zinc/sangre , Zinc/uso terapéuticoAsunto(s)
Eritema/diagnóstico , Satisfacción del Paciente/estadística & datos numéricos , Psoriasis/terapia , Autocuidado/métodos , Terapia Ultravioleta/métodos , Adulto , Anciano , Estudios Transversales , Eritema/etiología , Eritema/prevención & control , Femenino , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente/estadística & datos numéricos , Medición de Resultados Informados por el Paciente , Autocuidado/efectos adversos , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios/estadística & datos numéricos , Factores de Tiempo , Resultado del Tratamiento , Terapia Ultravioleta/efectos adversosRESUMEN
BACKGROUND: Postacne scarring is an unfortunate and frequent complication of acne, with varied morphological forms and associated significant psychological distress to patients. AIM OF THE WORK: To evaluate the efficacy and safety of plasma gel injection alone and in combination with microneedling in treatment of atrophic postacne scars. PATIENTS AND METHODS: Sixty patients with atrophic postacne scars were enrolled in this single blinded randomized controlled study. The patients were divided into three groups with 20 patients being treated with intradermal injection of plasma gel, 20 patients treated with dermaroller, and 20 patients subjected to combined plasma gel and dermaroller. Patients received four sessions at monthly intervals and were evaluated by clinical, histopathological, and immunohistochemical analysis. RESULTS: There was statistically significant improvement in postacne scars after treatment in all studied groups with variable degrees; the combined technique showed the best clinical improvement in postacne scars. There was an increase in newly formed collagen and elastic fibers with more organized and condensed bundles after the end of treatment. CONCLUSION: Plasma gel showed a remarkable improvement for most patients after one session, providing a quick and easy solution for acne scars. The combination of dermaroller and plasma gel potentiated its effect with more improvement in scars.
Asunto(s)
Acné Vulgar/complicaciones , Transfusión de Sangre Autóloga/métodos , Cicatriz/terapia , Técnicas Cosméticas/efectos adversos , Plasma Rico en Plaquetas , Adulto , Atrofia/etiología , Atrofia/terapia , Biopsia , Transfusión de Sangre Autóloga/efectos adversos , Cicatriz/diagnóstico , Cicatriz/etiología , Terapia Combinada/efectos adversos , Terapia Combinada/métodos , Punción Seca/efectos adversos , Punción Seca/instrumentación , Punción Seca/métodos , Eritema/diagnóstico , Eritema/epidemiología , Eritema/etiología , Femenino , Estudios de Seguimiento , Geles , Humanos , Inyecciones Intralesiones/efectos adversos , Masculino , Índice de Severidad de la Enfermedad , Piel/patología , Resultado del Tratamiento , Adulto JovenRESUMEN
Minimal erythema dose (MED) testing is frequently used in clinical settings for determining the smallest amount of ultraviolet (UV) irradiation necessary to produce erythema (inflammatory reddening) on the surface of the skin. In this context, the MED is regarded as a key factor in determining starting doses for UV phototherapy for common skin conditions such as psoriasis and eczema. In research settings, MED testing also has potential to be a powerful tool for assessing within- and between-persons variation in inflammatory responses. However, MED testing has not been widely adopted for use in research settings, likely owing to a lack of published guidelines, which is a barrier to obtaining reproducible results from this assay. Also, protocols and equipment for establishing MED vary widely, making it difficult to compare results across laboratories. Here, we describe a precise and reproducible method to induce and measure superficial erythema using newly designed protocols and methods that can easily be adapted to other equipment and laboratory environments. The method described here includes detail on procedures that will allow extrapolation of a standardized dosage schedule to other equipment so that this protocol can be adapted to any UV radiation source.
Asunto(s)
Eritema/diagnóstico , Eritema/etiología , Inflamación/etiología , Inflamación/patología , Piel/patología , Piel/efectos de la radiación , Rayos Ultravioleta/efectos adversos , Relación Dosis-Respuesta en la Radiación , Humanos , RadiometríaRESUMEN
BACKGROUND: Intense pulsed light therapy (IPL) decreases facial erythema and telangiectasias associated with rosacea. Topical skin care products decrease facial erythema by the action of active ingredients and masking effects. OBJECTIVES: To assess the efficacy and tolerability of combining a topical skin care regimen (TSCR) comprised of a multifunctional three-in-one facial cream and a mineral-based brush-on SPF50 powder sunscreen with a single IPL treatment for treating mild-to-severe facial redness associated with rosacea. METHODS: Twenty female subjects with Fitzpatrick skin types I-III received TSCR monotherapy for 12 weeks. At that time, subjects received a single IPL treatment and continued TSCR for 6 additional weeks. Subjects were evaluated at Baseline and at Weeks 4, 8, 12, and 18. RESULTS: Using a 7-point redness scale, the overall mean (SD) redness score significantly improved from 3.05 (0.97) at baseline to 2.05 (0.76) at Week 18 (P < 0.01). There was a decrease in investigator-rated erythema from baseline (bare skin) to Week 12 (bare skin, before IPL) when TSCR was used as monotherapy which did not achieve significance (P = 0.12). Most subjects (80%) were satisfied or Very satisfied with the TSCR at Week 18. All subjects (100%) agreed that it improved their baseline skin redness and most (85%) would recommend TSCR to others. TSCR was well-tolerated with no significant changes in skin dryness, scaling, or itching. Mild burning occurred immediately following the IPL treatment at Week 12. CONCLUSION: TSCR in combination with a single IPL treatment produced a significant improvement in overall facial redness in patients with rosacea. Longer-term treatment with TSCR may produce continued improvement.
Asunto(s)
Eritema/terapia , Tratamiento de Luz Pulsada Intensa/efectos adversos , Rosácea/terapia , Crema para la Piel/administración & dosificación , Telangiectasia/terapia , Adolescente , Adulto , Anciano , Terapia Combinada/efectos adversos , Terapia Combinada/métodos , Eritema/diagnóstico , Eritema/etiología , Cara , Femenino , Humanos , Persona de Mediana Edad , Satisfacción del Paciente , Rosácea/complicaciones , Rosácea/diagnóstico , Índice de Severidad de la Enfermedad , Piel/efectos de los fármacos , Piel/efectos de la radiación , Crema para la Piel/efectos adversos , Protectores Solares/administración & dosificación , Protectores Solares/efectos adversos , Telangiectasia/diagnóstico , Telangiectasia/etiología , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Dual-release mechanism of ethosomal gels (ie, ethosomes and gel) makes them as versatile drug delivery systems for topical applications. Clove oil is obtained from the clove buds exhibited broad antifungal and antibacterial activity. Cutaneous candidiasis is the infection caused by Candida albicans or other Candida species. AIM: The aim of the present study was to prepare ethosomal gel of clove oil and evaluate its effectiveness in the treatment of cutaneous candidiasis. METHODS: Ethosomes of clove oil was formulated by using varying concentrations of soyaphosphotidyl choline and ethanol, and later, it was incorporated into carbapol 974 base gels to form ethosomal gel. The prepared ethosomal gels were also evaluated for spreadability, drug release studies, ex vivo permeation study, and antifungal activity. RESULTS: The optimized formulation did not cause any irritation to the skin since the pH of formulation was in the pH range of skin. The ethosomal gel showed satisfactory antifungal activity against the fungus C. albicans compared to pure clove oil. CONCLUSIONS: The results showed that developed formulation could be promising one in the topical delivery of clove oil for the treatment of cutaneous candidiasis.
Asunto(s)
Candida albicans/efectos de los fármacos , Candidiasis Cutánea/tratamiento farmacológico , Aceite de Clavo/administración & dosificación , Piel/efectos de los fármacos , Administración Cutánea , Animales , Candidiasis Cutánea/microbiología , Aceite de Clavo/efectos adversos , Aceite de Clavo/farmacocinética , Evaluación Preclínica de Medicamentos , Liberación de Fármacos , Eritema/inducido químicamente , Eritema/diagnóstico , Femenino , Geles , Liposomas , Masculino , Pruebas de Sensibilidad Microbiana , Ratas , Índice de Severidad de la Enfermedad , Absorción Cutánea/efectos de los fármacosRESUMEN
BACKGROUND: Elevated levels of skin sebum are associated with the growth of Propionibacterium acnes. Intensive degreasing of the skin reduces Propionibacterium acnes but also may cause skin irritation. AIMS: We assessed the degreasing effect and skin tolerability of a botanical face cleanser with hops and willow bark extract and disodium cocoyl glutamate as mild cleansing agent compared to a standard face cleanser with sodium laureth sulfate (SLES). MATERIALS AND METHODS: A total of 21 healthy volunteers with normal to oily skin were enrolled in this study. Both cleansers were applied twice a day on the left or right side of the forehead for 15 days in a standardized manner. Bioengineering measurements were performed on day 8 and 15 and on day 17 after an application break of 48 hours. The sebum level was determined using a Sebumeter® , and skin redness was measured using a Mexameter® . RESULTS: The botanical face cleanser significantly reduced the sebum level (P < .01) in the test area on day 17. The SLES containing cleanser showed a statistically relevant degreasing effect already on day 15, but after the application break the sebum level increased again on day 17. None of the cleansers caused skin irritation as determined by skin redness measurements. CONCLUSIONS: In contrast to the SLES containing cleanser, the botanical skin cleanser with hops and willow bark extract had a continuous degreasing effect without reactive seborrhoe after the treatment break. Skin cleansing without SLES might be advantageous for sensitive skin.
Asunto(s)
Eritema/diagnóstico , Extractos Vegetales/administración & dosificación , Sebo/efectos de los fármacos , Crema para la Piel/administración & dosificación , Piel/efectos de los fármacos , Adulto , Eritema/inducido químicamente , Femenino , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Fotometría , Extractos Vegetales/efectos adversos , Extractos Vegetales/química , Sebo/metabolismo , Índice de Severidad de la Enfermedad , Piel/diagnóstico por imagen , Piel/metabolismo , Crema para la Piel/efectos adversos , Crema para la Piel/química , Dodecil Sulfato de Sodio/administración & dosificación , Dodecil Sulfato de Sodio/efectos adversos , Dodecil Sulfato de Sodio/análogos & derivados , Resultado del Tratamiento , Adulto JovenRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto , Pénfigo Familiar Benigno/diagnóstico , Pénfigo Familiar Benigno/terapia , Fototerapia/métodos , Eritema/diagnóstico , Prednisona/administración & dosificación , Cuello/patología , Axila/patología , Ingle/patología , Extremidad Superior/patología , Eritema/patología , Mupirocina/administración & dosificación , Azoles/administración & dosificación , Fluconazol/administración & dosificación , Clotrimazol/administración & dosificación , Betametasona/administración & dosificaciónRESUMEN
El eritema polimorfo solar es la fotodermatosis más frecuente y suele aparecer en primavera con la primera exposición intensa al sol. Sus manifestaciones cutáneas son variadas y el diagnóstico se basa en la clínica junto al antecedente de exposición solar. En los casos leves, la fotoprotección suele ser suficiente para el control de la enfermedad, pero en formas más graves se requieren otras terapéuticas, como corticoides, antihistamínicos, o fototerapia, que genera una "fotoadaptación" de las áreas de piel afectadas. Presentamos un caso típico de erupción polimorfa solar que respondió de forma adecuada a medidas de fotoprotección. (AU)
The polymorphic solar eruption is the most frequent photodermatosis, and usually appears in spring with the first intense exposure to the sun. It has multiple cutaneous manifestations, and its diagnosis is based on the clinic and the antecedent of solar exposition. In mild cases, photoprotection is usually enough to control the disease, but in more severe forms, other therapies are required, such as corticosteroids, antihistamines, or phototherapy to generate a "photo-adaptation" of the affected skin areas. We present a typical case of polymorphic solar eruption that responded adequately to photoprotection measurements. (AU)
Asunto(s)
Humanos , Femenino , Adulto , Trastornos por Fotosensibilidad/diagnóstico , Luz Solar/efectos adversos , Eritema/diagnóstico , Fototerapia , Trastornos por Fotosensibilidad/inmunología , Trastornos por Fotosensibilidad/patología , Calidad de Vida , Estaciones del Año , Protectores Solares/uso terapéutico , Azatioprina/uso terapéutico , Talidomida/uso terapéutico , Rayos Ultravioleta/efectos adversos , Terapia Ultravioleta , Corticoesteroides/uso terapéutico , Colecalciferol/uso terapéutico , Eritema/etiología , Eritema/inmunología , Eritema/patología , Antagonistas de los Receptores Histamínicos/uso terapéutico , Antimaláricos/uso terapéuticoRESUMEN
Pemetrexed is a multi-targeted folate antagonists approved for non-small cell lung cancer and other malignancies. Adverse cutaneous reactions have been reported in up to 1/3 of patients treated. A rare cutaneous adverse reaction is pseudocellulitis. We report about a 62-year-old male patient treated with a combination of cisplatin and pemetrexed for non-small cell lung cancer stage IV who developed about 4 months after initiation of treatment painful, non-febrile erythematous lesions on feet and lower legs. There was no lymphadenopathy and no general malaise. Laboratory investigations detected increased level of C-reactive protein but normal values of procalcitonin. A skin biopsy revealed a mild interface dermatitis. Antifolate treatment was stopped and he received oral and topical corticosteroids, compression therapy and supplementation with folate and vitamin B. A complete remission of skin eruptions was achieved. Pemetrexed-induced pseudocellulitis is a possible, but rare complication of treatment that oncologists and dermatologists should know. Systemic antibiosis is unnecessary.
Asunto(s)
Antineoplásicos/efectos adversos , Celulitis (Flemón)/diagnóstico , Edema/diagnóstico , Eritema/diagnóstico , Pemetrexed/efectos adversos , Diagnóstico Diferencial , Edema/inducido químicamente , Eritema/inducido químicamente , Humanos , Masculino , Persona de Mediana EdadAsunto(s)
Dolor Abdominal/terapia , Analgésicos Opioides/efectos adversos , Eritema/etiología , Calor/efectos adversos , Hiperpigmentación/etiología , Manejo del Dolor/efectos adversos , Pigmentación de la Piel , Piel/patología , Síndrome de Abstinencia a Sustancias/terapia , Dolor Abdominal/inducido químicamente , Dolor Abdominal/diagnóstico , Analgésicos Opioides/administración & dosificación , Eritema/diagnóstico , Humanos , Hiperpigmentación/diagnóstico , Masculino , Persona de Mediana Edad , Síndrome de Abstinencia a Sustancias/diagnósticoRESUMEN
AIMS: Oesophageal probes to monitor luminal oesophageal temperature (LET) during atrial fibrillation (AF) catheter ablation have been proposed, but their effects remain unclear. Aim of this study is to evaluate the effects of an oesophageal temperature probe with insulated thermocouples. METHODS AND RESULTS: Patients with symptomatic, drug-refractory paroxysmal or persistent AF who underwent left atrial radiofrequency (RF) catheter ablation were prospectively enrolled. Patients were ablated using a single-tip RF contact force ablation catheter. An intraluminal oesophageal temperature probe was used in Group 1. In Group 2, patients were ablated without LET monitoring. Assessment of asymptomatic endoscopically detected oesophageal lesions (EDEL) was performed by oesophagogastroduodenoscopy (EGD) in all patients. Eighty patients (mean age 63.7 ± 10.7 years; men 56%) with symptomatic, drug-refractory paroxysmal (n = 28; 35%) or persistent AF were included. Group 1 and Group 2 patients (n = 40 in each group) were comparable in regard to baseline characteristics, but RF duration on the posterior wall was significantly shorter in Group 1 patients. Overall, seven patients (8.8%) developed EDEL (four ulcerations, three erythema). The incidence of EDEL in Group 1 and Group 2 patients was comparable (7.5 vs. 10%, P = 1.0). No major adverse events were reported in both groups. CONCLUSION: According to these preliminary results, the use of oesophageal temperature probes with insulated thermocouples seems to be feasible in patients undergoing AF RF catheter ablation. The incidence of post-procedural EDEL when using a cut-off of 39°C is comparable to the incidence of EDEL without using a temperature probe.